These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27867027)

  • 21. Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.
    Liu J; Sun B; Yin H; Liu S
    Medicine (Baltimore); 2016 Apr; 95(14):e3150. PubMed ID: 27057839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An essential cell-autonomous role for hepcidin in cardiac iron homeostasis.
    Lakhal-Littleton S; Wolna M; Chung YJ; Christian HC; Heather LC; Brescia M; Ball V; Diaz R; Santos A; Biggs D; Clarke K; Davies B; Robbins PA
    Elife; 2016 Nov; 5():. PubMed ID: 27897970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in iron metabolism research].
    Kawabata H
    Rinsho Ketsueki; 2017; 58(10):1864-1871. PubMed ID: 28978826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling pathways regulating hepcidin.
    Rishi G; Subramaniam VN
    Vitam Horm; 2019; 110():47-70. PubMed ID: 30798816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepcidin and iron disorders: new biology and clinical approaches.
    Arezes J; Nemeth E
    Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of iron metabolism: Clinical and therapeutic implications.
    Conde Diez S; de Las Cuevas Allende R; Conde García E
    Med Clin (Barc); 2017 Mar; 148(5):218-224. PubMed ID: 28073521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.
    Babitt JL; Huang FW; Xia Y; Sidis Y; Andrews NC; Lin HY
    J Clin Invest; 2007 Jul; 117(7):1933-9. PubMed ID: 17607365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biology of the iron efflux transporter, ferroportin.
    Rishi G; Subramaniam VN
    Adv Protein Chem Struct Biol; 2021; 123():1-16. PubMed ID: 33485480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepcidin Mediates Transcriptional Changes in Ferroportin mRNA in Differentiated Neuronal-Like PC12 Cells Subjected to Iron Challenge.
    Helgudottir SS; Lichota J; Burkhart A; Moos T
    Mol Neurobiol; 2019 Apr; 56(4):2362-2374. PubMed ID: 30027341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
    Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
    Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The regulation of hepcidin and its effects on systemic and cellular iron metabolism.
    Fleming MD
    Hematology Am Soc Hematol Educ Program; 2008; ():151-8. PubMed ID: 19074074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the structure/activity relationships of the iron regulatory peptide hepcidin.
    Clark RJ; Tan CC; Preza GC; Nemeth E; Ganz T; Craik DJ
    Chem Biol; 2011 Mar; 18(3):336-43. PubMed ID: 21439478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing the Dual Nature of Iron to Preserve Health.
    Silvestri L; Pettinato M; Furiosi V; Bavuso Volpe L; Nai A; Pagani A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the hepcidin-ferroportin axis and iron in cancer.
    Wu XN; Su D; Wang L; Yu FL
    Eur J Cancer Prev; 2014 Mar; 23(2):122-33. PubMed ID: 23676854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
    Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
    Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepcidin and its potential clinical utility.
    Miseta A; Nagy J; Nagy T; Poór VS; Fekete Z; Sipos K
    Cell Biol Int; 2015 Nov; 39(11):1191-202. PubMed ID: 26109250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hepcidin in iron metabolism.
    Nemeth E; Ganz T
    Acta Haematol; 2009; 122(2-3):78-86. PubMed ID: 19907144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.